Latest Fertiliser News

Ridley Corporation reported solid FY25 results with EBITDA up 8.6% to $97.8 million and NPAT rising 8.7% to $43.3 million, underpinned by strategic acquisitions and disciplined capital management.

Ridley Corporation Limited reported a solid FY25 with revenue up 3.1% to $1.3 billion and net profit after tax rising 8.7% to $43.3 million. The company declared a fully franked final dividend of 5.00 cents per share, signaling confidence in its diversified growth strategy.

Redox Ltd reported a robust 9.4% increase in revenue for FY25, supported by strong volume growth and three strategic acquisitions, despite margin compression and a challenging macroeconomic backdrop.

Minbos Resources has partnered exclusively with Fertiafrica to produce Angola’s first locally granulated fertilisers, aiming to transform the country’s agricultural landscape with affordable, high-quality products.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

Terragen Holdings reports rapid customer growth for its new dry probiotics, secures a US patent, and posts promising crop trial results, signaling strong momentum in its agricultural biotech offerings.

ABx Group Limited reports promising rare earth exploration results in Tasmania, steady progress on its ALCORE fluorine recycling pilot plant, and advancing bauxite mining projects in Queensland and Tasmania, while managing funding challenges.

PhosCo Ltd reports significant progress at its Gasaat Phosphate Project in Tunisia, unveiling promising drilling results and securing potential strategic investment from the EBRD to fund its next development phase.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Memphasys Limited has submitted its Felix™ sperm separation system for CE Mark approval, targeting Europe’s $5 billion IVF market, while expanding direct sales in Japan and validating its RoXsta™ oxidative stress diagnostic platform.

Vitrafy Life Sciences reported robust progress in Q4 FY2025, advancing its cryopreservation technology and commercial partnerships while preparing for a pivotal product launch in FY2026.

Great Western Exploration advances its copper-gold exploration at the Oval and Juggernaut projects, unveiling the strongest geochemical signatures yet and initiating a detailed gravity survey to refine drill targets.